비교리스트

 카트 문의
시장보고서
상품코드
1571375

전자 환자 보고 결과 시장 규모 및 예측, 세계 및 지역별 점유율, 동향, 성장 기회 분석 보고서 : 전달 모드별, 용도별, 최종사용자별, 지역별

Electronic Patient-Reported Outcomes Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Delivery Mode, Application, End User, and Geography
발행일: | 리서치사: The Insight Partners | 페이지 정보: 영문 149 Pages | 배송안내 : 즉시배송

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

당사의 최신 조사 보고서인 '2031년까지 전자 환자 보고 결과(ePROS) 시장 예측 - 세계 분석 - 전달 모드, 용도, 최종사용자 및 지역별 분석'에 따르면, 시장은 2023년 8억 4,377만 달러에서 2031년 28억 6,800만 달러에 달할 것으로 예상됩니다. 2023년부터 2031년까지 16.5%의 CAGR을 기록할 것으로 예측됩니다. 임상시험 수가 크게 증가함에 따라 임상시험 아웃소싱 관행이 확산되고, 연구개발 활동이 급증하는 제약 업계의 신흥국 시장이 전자 환자 보고 결과(ePROS) 시장의 성장에 기여하고 있습니다. 그러나 데이터 프라이버시 및 보안 문제가 시장 성장을 저해하는 요인으로 작용하고 있습니다. 또한, 인공지능과 머신러닝을 ePROS 플랫폼에 통합하는 것은 향후 몇 년 동안 새로운 전자 환자 보고 결과(ePROS) 시장 동향을 가져올 것으로 예상됩니다.

2023년 전 세계 전자 환자 보고 결과(ePROS) 시장에서 북미가 큰 비중을 차지했습니다. 북미 전자 환자 보고 결과(ePROS) 시장은 미국, 캐나다, 멕시코로 구분됩니다. 미국은 북미에서 가장 발전된 국가 중 하나입니다. 미국은 환자 중심의 의료 서비스를 제공하는 데 도움이 되는 디지털 헬스 기술의 사용이 증가함에 따라 주요 시장 점유율을 차지하고 있습니다. 여기에는 헬스케어 서비스를 소프트웨어 및 하드웨어와 통합하여 앱, 웨어러블 기기 및 기타 기기의 도움을 받아 관리 및 모니터링할 수 있는 소프트웨어 및 하드웨어가 포함됩니다. 만성질환 관리에 대한 관심이 높아짐에 따라 지속적인 평가와 적시에 개입할 수 있는 ePROS에 대한 수요가 증가하고 있습니다. 미국 임상종양학회(American Society of Clinical Oncology)가 2023년 6월에 발표한 논문에 따르면, 미국에서는 메디케어 및 메디케이드 혁신센터(Centers for Medicare and Medicaid Innovation Innovation)의 대체 지불 모델 시험(Enhancing Oncology Model)에 ePROS가 포함된 것은 ePROS의 도입이 고품질의 혁신적 암 치료의 핵심이 될 수 있다는 것을 보여주며, 보다 폭넓은 도입을 촉진할 가능성이 높습니다. 국내 임상시험의 급증은 ePROS에 대한 수요를 증가시킬 것으로 예상됩니다. 시장 관계자들은 제품 출시, 제품 승인, 제휴 등 전자 환자 보고 결과(ePROS) 시장에 대한 전략적 이니셔티브를 취하고 있으며, 이는 시장 성장을 더욱 증폭시킬 것으로 예상됩니다. 예를 들어, 2024년 6월 Evidation은 조사 데이터, 전자 환자 보고 결과(ePROS), 웨어러블 데이터, 증거 기반 컨텐츠를 활용하여 개인이 편두통을 더 잘 이해하고 관리할 수 있도록 돕는 Evidation 앱의 건강 참여 경험과 증상 추적 프로그램인 MigraineSmart를 발표했습니다. 따라서 디지털 의료 기술의 증가, 환자 중심 치료에 대한 수요 급증, 시장 참여자들의 전략적 이니셔티브 증가는 향후 몇 년 동안 ePROSs 시장의 성장을 촉진할 것으로 예상됩니다.

캐나다의 전자 관련 환자 결과(ePROS) 시장은 디지털 건강 기술 채택 증가와 웨어러블 사용 증가에 힘입어 성장하고 있습니다. 의료 분야의 기술 통합은 전자 의료 기록(EHR)의 도입으로 이어져 원격의료 서비스에 대한 수요를 창출했습니다. 캐나다 정부는 캐나다의 디지털 의료 기술을 촉진하기 위한 이니셔티브를 취하고 있습니다. 예를 들어, 2018년 4월 캐나다 보건부는 '의약품 및 의료기기 규제 심사' 이니셔티브에 따라 치료제품국 의료기기국 내에 새로운 부서를 신설하여 디지털 헬스 분야의 빠르게 변화하는 기술에 적응하고 빠른 혁신 주기에 대응하기 위해 디지털 헬스 기술에 대한 보다 정밀한 시판 전 평가가 가능하도록 했습니다. 평가할 수 있게 되었습니다. Innovative Medicines Canada에 따르면, 캐나다는 전 세계 임상시험의 3.1%를 차지하고 있으며, 캐나다의 임상시험 건수가 증가함에 따라 기술의 도움을 받아 사무를 줄이고 효율성을 높이는 ePROS에 대한 수요가 증가하고 있습니다. 따라서 디지털 의료 기술 채택이 증가하고 임상시험 수가 급증하면서 임상시험의 효율적인 모니터링을 위한 ePROS에 대한 수요가 증가하고 있으며, 이는 ePROS(전자 환자 보고 결과) 시장의 성장을 주도하고 있습니다.

전자 환자 보고 결과(ePROS)에 대한 전략적 접근은 향후 시장 기회를 가져올 것입니다.

전자 환자 보고 결과(ePROSs) 시장은 예측 기간 동안 원격의료 및 임상시험을 위한 원격 모니터링의 채택이 증가함에 따라 유리한 기회를 경험할 것으로 예상됩니다. 원격의료 및 원격 모니터링 솔루션을 통해 원격지나 의료 서비스가 부족한 지역의 환자들은 집에서 실시간으로 정보를 보고할 수 있어 환자 데이터에 대한 접근성을 높일 수 있습니다. 건강 데이터는 웨어러블 및 연결된 의료 시스템과 같은 원격 모니터링 기기를 통해 지속적으로 전송될 수 있으며, ePROS 시스템과 결합하면 의료 전문가가 환자의 상태에 대한 자세한 정보를 실시간으로 받아 보다 정확하고 정기적인 개입을 할 수 있습니다. 예를 들어, 비바링크의 통합 급성기 원격 환자 모니터링 솔루션은 실시간 심전도를 포함한 환자 바이탈의 지속적인 실시간 모니터링과 함께 바이탈 및 생체 정보, EPRO/ECOA/조사, 중앙 집중식 데이터 서비스, 원격 데이터 수집, 환자 순응도에 대한 정보를 제공합니다. ePROS 시스템의 효과는 원격의료 및 원격 모니터링의 발전에 따라 확대되고 있으며, 환자 중심 진료의 중요한 요소로 자리매김하고 있습니다.

환자 중심 진료에 대한 관심이 높아지면서 전자 환자 보고 결과(ePROS) 시장의 성장을 견인하고 있습니다. 환자의 경험, 결과, 선호도를 우선시하는 방향으로 전환되면서 환자 피드백을 실시간으로 수집할 수 있는 도구에 대한 수요가 증가하고 있습니다. 헬스케어가 더욱 개인화되고 가치 기반이 되면서 ePROS를 통해 환자 보고에 의한 건강 결과를 실시간으로 추적할 수 있게 되었습니다. 더 나은 건강 결과는 각 환자의 필요에 따라 맞춤화된 치료를 통해 지원될 수 있습니다. 의료기관의 초점이 환자 경험과 만족도에 맞춰지면서 ePROS와 같은 디지털 도구의 사용이 증가하고 있습니다. 이 기술을 활용하면 환자는 스트레스를 덜 받고, 의료진은 정확한 데이터에 접근하여 지속적인 피드백을 받을 수 있습니다. 이러한 변화는 디지털 건강 기술의 혁신을 촉진하고 ePROS가 의료 절차에 통합될 수 있도록 지원합니다. 예를 들어, ePROS 도구와 전자 의료 기록(EHR) 시스템과의 통합이 진행됨에 따라 의료 서비스 제공자는 환자의 결과를 쉽게 모니터링할 수 있습니다. 이를 통해 환자가 보고한 선호도 및 경험에 대한 임상적 결정의 정합성을 쉽게 확인할 수 있습니다. 따라서 환자 중심 진료에 대한 이해도가 높아질수록 ePROS의 활용도가 높아질 것입니다.

전자 환자 보고 결과(ePROS) 시장 : 경쟁 상황 및 주요 발전

OpenClinica LLC, Buddy Healthcare Ltd Oy, Castor, Medable Inc, Assistek, Signant Health, Crucial Data Solutions, Curebase, Y-Prime LLC, Clinical Ink Inc, Medidata Solutions, Veeva Systems Inc, Medrio, PatientIQ 등이 전자 환자 보고 결과(ePROS) 시장에서 활동하는 주요 기업입니다.

미국 식품의약국, 질병통제예방센터(CDC), ClinicalTrials.gov는 ePROS(Electronic Patient Reported Outcomes) 시장 보고서를 작성할 때 참고한 1차 및 2차 정보 중 하나입니다.

목차

제1장 소개

제2장 주요 요약

  • 주요 인사이트

제3장 조사 방법

  • 2차 조사
  • 1차 조사
    • 가설 책정
    • 거시경제 요인 분석
    • 기초 수치 작성
    • 데이터 삼각측량
    • 국가 레벨 데이터

제4장 전자 환자 보고 결과(ePROS) 시장 상황

  • PEST 분석
  • ePROS의 이점
  • 임상시험에서 ePROS 이용
  • 각국의 ePROS 사용 병원 리스트

제5장 전자 환자 보고 결과(ePROS) 시장 - 주요 시장 역학

  • 전자 환자 보고 결과(ePROS) 시장 - 주요 시장 역학
  • 시장 성장 촉진요인
    • 전자 환자 보고 결과(ePROS)의 새로운 용도
    • 환자 중심 케어에 대한 주목 상승
  • 시장 성장 억제요인
    • 데이터 프라이버시와 보안 문제
  • 시장 기회
    • 원격의료와 원격 모니터링 채용 증가
  • 향후 동향
    • 인공지능과 머신러닝의 ePROS 플랫폼으로의 통합
  • 성장 촉진요인과 억제요인의 영향

제6장 전자 환자 보고 결과(ePROS) 시장 : 세계 시장 분석

  • 전자 환자 보고 결과(ePROS) 시장 매출, 2021-2031년
  • 전자 환자 보고 결과(ePROS) 시장 예측 분석

제7장 전자 환자 보고 결과(ePROS) 시장 : 배포 방식별

  • 클라우드 기반
  • 온프레미스

제8장 전자 환자 보고 결과(ePROS) 시장 : 용도별

  • 종양학
  • 호흡기
  • 기타

제9장 전자 환자 보고 결과(ePROS) 시장 : 최종사용자별

  • CRO
  • 제약회사
  • 기타

제10장 전자 환자 보고 결과(ePROS) 시장 : 지역별

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 기타 유럽
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 한국
    • 호주
    • 기타 아시아태평양
  • 중남미
    • 브라질
    • 아르헨티나
    • 기타 중남미
  • 중동 및 아프리카
    • 사우디아라비아
    • 남아프리카공화국
    • 아랍에미리트
    • 기타 중동 및 아프리카

제11장 전자 환자 보고 결과(ePROS) 시장 - 업계 상황

  • 전자 환자 보고 결과(ePROS) 시장 성장 전략
  • 유기적 성장 전략
  • 무기적 성장 전략

제12장 기업 개요

  • OpenClinica LLC
  • Buddy Healthcare Ltd Oy
  • Castor
  • Medable Inc
  • Assistek
  • Signant Health
  • Crucial Data Solutions
  • Curebase
  • Y-Prime LLC
  • Clinical Ink Inc
  • Medidata Solutions
  • Veeva Systems Inc
  • Medrio
  • PatientIQ

제13장 부록

ksm 24.10.25

According to our new research study on "Electronic Patient-Reported Outcomes (ePROS) Market Forecast to 2031 -Global Analysis - by Delivery Mode, Application, End User, and Geography," the market is anticipated to grow from US$ 843.77 million in 2023 and is projected to reach US$ 2,868.00 million by 2031; it is expected to register a CAGR of 16.5% during 2023-2031. The practice of outsourcing clinical studies with a massive rise in the number of trials and the flourishing pharmaceutical industry with a surge in research and development activities are contributing to the electronic patient-reported outcomes (ePROS) market growth. However, the data privacy and security issues hamper market growth. Further, the integration of artificial intelligence and machine learning with ePROS platforms is expected to bring new electronic patient-reported outcomes (ePROS) market trends in the coming years.

North America accounted for a major share of the global electronic patient-reported outcomes (ePROS) market in 2023. The North America electronic patient-reported outcomes (ePROS) market is segmented into the US, Canada, and Mexico. The US is one of the most developed countries in North America. The country accounts for the major market share owing to the increasing use of digital health technologies, which helps provide patient-centered care. This involves integrating healthcare services with software and hardware, which can be managed and monitored with the help of apps, wearable devices, and other devices. The increasing focus on chronic disease management has increased the demand for ePROs as they allow continuous assessment and timely interventions. As per the article published by the American Society of Clinical Oncology in June 2023, in the US, ePRO inclusion in the Centers for Medicare and Medicaid Innovation's alternative payment model pilot, the Enhancing Oncology Model, is a sign that ePRO implementation should be a mainstay of high-quality and transformational cancer care and is likely to foster broader adoption. The surging number of clinical trials in the country is expected to increase the demand for ePROs. Market players are taking electronic related patient outcomes (ePROS) market strategic initiatives such as product launches, product approvals, and collaborations, which are further expected to amplify the market growth. For instance, in June 2024, Evidation launched MigraineSmart, which is a health engagement experience and symptom tracking program on the Evidation app that harnesses survey data, electronic patient reported outcomes (ePROs), wearable data, and evidence-based content to make it possible for individuals to better understand and manage their migraines. Therefore, an increase in digital health technologies, a surge in demand for patient-centered care, and increase in strategic initiatives by market players are expected to fuel the growth of the ePROs Market in the coming years.

The Canada electronic related patient outcomes (ePROS) market is driven by the rise in the adoption of digital health technologies and the increased use of wearables. The integration of technology in healthcare has resulted in the implementation of the electronic health record (EHR) and generated the demand for telehealth services. The government of Canada has taken initiatives to promote digital health technologies in the country. For instance, in April 2018, under the "Regulatory Review of Drugs and Devices" initiative, the Health Canada founded a new division within the Therapeutic Products Directorate's Medical Devices Bureau, which allows more targeted pre-market evaluation of digital health technologies to adapt to fast changing technologies in digital health and respond to fast innovation cycles. The increasing number of clinical trials in Canada has fueled the demand for ePROs to reduce the paperwork and increase efficiency with the help of technology. According to Innovative Medicines Canada, Canada accounts for the 3.1% in global clinical trials. Therefore, increasing adoption of digital health technologies and surging number of clinical trials have created a demand for ePROs for efficient monitoring of clinical trials driving the growth of electronic related patient outcomes (ePROS) market.

Strategic Initiatives in Electronic Patient-Reported Outcomes (ePROS) to Provide Market Opportunities in Future

The market for electronically reported patient outcomes (ePROs) is expected to experience lucrative opportunities with the rising adoption of telehealth and remote monitoring for clinical trials during the forecast period. Patients in remote or underserved areas can report real-time information from the comfort of their homes owing to telehealth and remote monitoring solutions, which increase accessibility of patient data. Health data can be continuously transmitted via remote monitoring devices, such as wearables and linked health systems. When coupled with ePRO systems, medical professionals receive detailed information regarding a patient's condition in real time, enabling more precise and regular interventions. For example, Vivalink's integrated acute remote patient monitoring solution provides continuous and real-time monitoring of patient vitals, including live ECG, as well as information about vitals and biometrics, EPRO/ECOA/surveys, centralized data services, remote data collection, and patient adherence. The efficacy of ePRO systems is expanded by telehealth and remote monitoring developments, establishing them as a crucial element of patient-centered care.

The growing emphasis on patient-centered care fuels the growth of the electronic patient-reported outcomes (ePROS) market. Tools that gather patient feedback in real-time are in high demand owing to the shift toward prioritizing patient experiences, outcomes, and preferences. The real-time tracking of patient-reported health outcomes is made possible by ePROs as healthcare becomes more personalized and value-based. Better health outcomes are supported by ensuring treatments are tailored to each patient's needs. The use of digital tools such as ePROs has increased as the focus of healthcare facilities shifts to patient experience and satisfaction. With the help of this technology, patients can have less stress and receive continuous feedback by giving healthcare providers access to precise data. This change drives innovation in digital health technologies, supporting the integration of ePROs into medical procedures. For instance, healthcare providers can easily monitor patient outcomes owing to the growing integration of ePRO tools with electronic health record (EHR) systems. This facilitates the alignment of clinical decisions with the preferences and experiences that the patient has reported. Therefore, a greater understanding of patient-centered care propels the use of ePROs.

Electronic Patient-Reported Outcomes (ePROS) Market: Competitive Landscape and Key Developments

OpenClinica LLC, Buddy Healthcare Ltd Oy, Castor, Medable Inc, Assistek, Signant Health, Crucial Data Solutions, Curebase, Y-Prime LLC, Clinical Ink Inc, Medidata Solutions, Veeva Systems Inc, Medrio, and PatientIQ are among the key companies operating in the electronic patient-reported outcomes (ePROS) market.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and ClinicalTrials.gov are among the primary and secondary sources referred to while preparing the electronic patient-reported outcomes (ePROS) market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Electronic Patient-Reported Outcomes (ePROS) Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Benefits of ePROs
  • 4.4 Use of ePRO in Clinical Trials
  • 4.5 List of Hospitals Using ePRO in each country

5. Electronic Patient-Reported Outcomes (ePROS) Market - Key Market Dynamics

  • 5.1 Electronic Patient-Reported Outcomes (ePROS) Market - Key Market Dynamics
  • 5.2 Market Drivers:
    • 5.2.1 Emerging Applications of Electronic Patient-Reported Outcomes (ePROS)
    • 5.2.2 Increasing Focus on Patient-Centered Care
  • 5.3 Market Restraints
    • 5.3.1 Data Privacy and Security Issues
  • 5.4 Market Opportunities
    • 5.4.1 Rising Adoption of Telehealth and Remote Monitoring
  • 5.5 Future Trends
    • 5.5.1 Integration of Artificial Intelligence and Machine Learning with ePROS Platforms
  • 5.6 Impact of Drivers and Restraints:

6. Electronic Patient-Reported Outcomes (ePROS) Market - Global Market Analysis

  • 6.1 Electronic Patient-Reported Outcomes (ePROS) Market Revenue (US$ Million), 2021-2031
  • 6.2 Electronic Patient-Reported Outcomes (ePROS) Market Forecast Analysis

7. Electronic Patient-Reported Outcomes (ePROS) Market Analysis - by Delivery Mode

  • 7.1 Cloud Based
    • 7.1.1 Overview
    • 7.1.2 Cloud Based: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 On-Premise
    • 7.2.1 Overview
    • 7.2.2 On-Premise: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)

8. Electronic Patient-Reported Outcomes (ePROS) Market Analysis - by Application

  • 8.1 Oncology
    • 8.1.1 Overview
    • 8.1.2 Oncology: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Respiratory
    • 8.2.1 Overview
    • 8.2.2 Respiratory: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Others
    • 8.3.1 Overview
    • 8.3.2 Others: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)

9. Electronic Patient-Reported Outcomes (ePROS) Market Analysis - by End User

  • 9.1 CROs
    • 9.1.1 Overview
    • 9.1.2 CROs: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Pharmaceutical Companies
    • 9.2.1 Overview
    • 9.2.2 Pharmaceutical Companies: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Others
    • 9.3.1 Overview
    • 9.3.2 Others: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)

10. Electronic Patient-Reported Outcomes (ePROS) Market - Geographical Analysis

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 North America Electronic Patient-Reported Outcomes (ePROS) Market Overview
    • 10.2.2 North America: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.2.3 North America: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast Analysis - by Delivery Mode
    • 10.2.4 North America: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast Analysis - by Application
    • 10.2.5 North America: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast Analysis - by End User
    • 10.2.6 North America: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast Analysis - by Country
      • 10.2.6.1 United States: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.2.6.1.1 United States: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode
        • 10.2.6.1.2 United States: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application
        • 10.2.6.1.3 United States: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User
      • 10.2.6.2 Canada: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.2.6.2.1 Canada: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode
        • 10.2.6.2.2 Canada: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application
        • 10.2.6.2.3 Canada: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User
      • 10.2.6.3 Mexico: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.2.6.3.1 Mexico: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode
        • 10.2.6.3.2 Mexico: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application
        • 10.2.6.3.3 Mexico: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User
  • 10.3 Europe
    • 10.3.1 Europe Electronic Patient-Reported Outcomes (ePROS) Market Overview
    • 10.3.2 Europe: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.3.3 Europe: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast Analysis - by Delivery Mode
    • 10.3.4 Europe: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast Analysis - by Application
    • 10.3.5 Europe: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast Analysis - by End User
    • 10.3.6 Europe: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast Analysis - by Country
      • 10.3.6.1 United Kingdom: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.6.1.1 United Kingdom: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode
        • 10.3.6.1.2 United Kingdom: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application
        • 10.3.6.1.3 United Kingdom: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User
      • 10.3.6.2 Germany: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.6.2.1 Germany: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode
        • 10.3.6.2.2 Germany: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application
        • 10.3.6.2.3 Germany: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User
      • 10.3.6.3 France: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.6.3.1 France: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode
        • 10.3.6.3.2 France: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application
        • 10.3.6.3.3 France: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User
      • 10.3.6.4 Italy: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.6.4.1 Italy: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode
        • 10.3.6.4.2 Italy: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application
        • 10.3.6.4.3 Italy: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User
      • 10.3.6.5 Spain: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.6.5.1 Spain: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode
        • 10.3.6.5.2 Spain: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application
        • 10.3.6.5.3 Spain: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User
      • 10.3.6.6 Rest of Europe: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.6.6.1 Rest of Europe: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode
        • 10.3.6.6.2 Rest of Europe: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application
        • 10.3.6.6.3 Rest of Europe: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific Electronic Patient-Reported Outcomes (ePROS) Market Overview
    • 10.4.2 Asia Pacific: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.4.3 Asia Pacific: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast Analysis - by Delivery Mode
    • 10.4.4 Asia Pacific: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast Analysis - by Application
    • 10.4.5 Asia Pacific: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast Analysis - by End User
    • 10.4.6 Asia Pacific: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast Analysis - by Country
      • 10.4.6.1 Japan: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.6.1.1 Japan: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode
        • 10.4.6.1.2 Japan: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application
        • 10.4.6.1.3 Japan: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User
      • 10.4.6.2 China: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.6.2.1 China: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode
        • 10.4.6.2.2 China: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application
        • 10.4.6.2.3 China: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User
      • 10.4.6.3 India: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.6.3.1 India: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode
        • 10.4.6.3.2 India: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application
        • 10.4.6.3.3 India: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User
      • 10.4.6.4 South Korea: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.6.4.1 South Korea: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode
        • 10.4.6.4.2 South Korea: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application
        • 10.4.6.4.3 South Korea: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User
      • 10.4.6.5 Australia: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.6.5.1 Australia: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode
        • 10.4.6.5.2 Australia: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application
        • 10.4.6.5.3 Australia: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User
      • 10.4.6.6 Rest of APAC: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.6.6.1 Rest of APAC: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode
        • 10.4.6.6.2 Rest of APAC: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application
        • 10.4.6.6.3 Rest of APAC: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User
  • 10.5 South & Central America
    • 10.5.1 South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Overview
    • 10.5.2 South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.5.3 South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast Analysis - by Delivery Mode
    • 10.5.4 South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast Analysis - by Application
    • 10.5.5 South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast Analysis - by End User
    • 10.5.6 South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast Analysis - by Country
      • 10.5.6.1 Brazil: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.6.1.1 Brazil: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode
        • 10.5.6.1.2 Brazil: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application
        • 10.5.6.1.3 Brazil: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User
      • 10.5.6.2 Argentina: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.6.2.1 Argentina: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode
        • 10.5.6.2.2 Argentina: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application
        • 10.5.6.2.3 Argentina: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User
      • 10.5.6.3 Rest of South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.6.3.1 Rest of South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode
        • 10.5.6.3.2 Rest of South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application
        • 10.5.6.3.3 Rest of South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User
  • 10.6 Middle East & Africa
    • 10.6.1 Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Overview
    • 10.6.2 Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.6.3 Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast Analysis - by Delivery Mode
    • 10.6.4 Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast Analysis - by Application
    • 10.6.5 Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast Analysis - by End User
    • 10.6.6 Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast Analysis - by Country
      • 10.6.6.1 Saudi Arabia: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.6.6.1.1 Saudi Arabia: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode
        • 10.6.6.1.2 Saudi Arabia: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application
        • 10.6.6.1.3 Saudi Arabia: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User
      • 10.6.6.2 South Africa: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.6.6.2.1 South Africa: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode
        • 10.6.6.2.2 South Africa: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application
        • 10.6.6.2.3 South Africa: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User
      • 10.6.6.3 United Arab Emirates: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.6.6.3.1 United Arab Emirates: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode
        • 10.6.6.3.2 United Arab Emirates: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application
        • 10.6.6.3.3 United Arab Emirates: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User
      • 10.6.6.4 Rest of Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.6.6.4.1 Rest of Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode
        • 10.6.6.4.2 Rest of Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application
        • 10.6.6.4.3 Rest of Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User

11. Electronic Patient-Reported Outcomes (ePROS) Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Electronic Patient-Reported Outcomes (ePROS) Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 OpenClinica LLC
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Buddy Healthcare Ltd Oy
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Castor
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Medable Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Assistek
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Signant Health
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Crucial Data Solutions
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Curebase
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Y-Prime LLC
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Clinical Ink Inc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Medidata Solutions
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 Veeva Systems Inc
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments
  • 12.13 Medrio
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments
  • 12.14 PatientIQ
    • 12.14.1 Key Facts
    • 12.14.2 Business Description
    • 12.14.3 Products and Services
    • 12.14.4 Financial Overview
    • 12.14.5 SWOT Analysis
    • 12.14.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제